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COMMENT
Wounds UK debate: 
dressing choice — what’s 
the X Factor?
I n November 2011, the Wounds UK Harrogate conference hosted the inaugural Wounds UK debate, which focused on the subject of 
dressings and how exactly clinicians are 
supposed to make the right choices for 
patients, especially when confronted 
with the plethora of new dressings and 
techniques available to today’s wound 
care specialist.
The debate aimed to find some answers 
to questions around what criteria to 
use when deciding on the suitability 
of particular dressing products. For 
example, does clinical need override 
cost, or should clinicians be guided 
purely by what is listed on the hospital 
formulary? The aim was to use an expert 
panel, a little like the popular TV show, 
to find the ‘X Factor’ of dressing choice.
FORMAT
The debate took place in the main 
auditorium at Harrogate International 
Conference Centre and was chaired  
by David Leaper, Emeritus Professor  
of Surgery, University of Newcastle  
upon Tyne.
The expert panel was specifically chosen 
to reflect a wide range of views and was 
made up of the following key opinion 
leaders in wound care:
 Karen Ousey, Reader in Advancing 
Clinical Practice, University of 
Huddersfield
 Julian Guest, Visiting Professor of 
Health Economics, Kings College, 
London and Director, Catalyst Health 
Economics Consultants,  Northwood, 
Middlesex
 Carol Roberts, Pharmacy and 
Prescribing Lead, East of England 
SHA
 Simon Barrett, Tissue Viability Nurse, 
East Riding of Yorkshire PCT.
The format of the debate was chosen to 
enhance audience engagement and to 
highlight the real problems of choosing 
the right dressing. Each member of 
the audience was given a red and a 
green card, which were to be used at 
the end of each presentation to rate 
the persuasiveness of each speaker 
— green indicated that the audience 
member agreed with the panel member’s 
proposals; red that they disagreed. At the 
end of the debate, the card scheme was 
used again to choose and overall ‘winner’.
SETTING THE SCENE
David Leaper chaired the debate and 
started off by looking at the range of 
competing interests that are available to 
the clinician when it comes to dressing 
choice, such as patient need, the clinical 
picture (e.g. the level of exudate/
infection), cost of a particular dressing 
versus other treatments, what is available 
on the formulary and the use of evidence-
‘The debate 
aimed to answer 
questions around 
the criteria for 
selecting dressing 
products’
DAVID LEAPER 
Emeritus Professor of Surgery, University 
of Newcastle upon Tyne
KAREN OUSEY
Reader in Advancing Clinical Practice, 
University of Huddersfield
SIMON BARRETT
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CAROL ROBERTS
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Kings College, London and Director, 
Catalyst Health Economics Consultants,   
Northwood, Middlesex David Leaper opening the debate.
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based practice. All of these methods have 
merits, but, how is the clinician supposed 
to choose? 
Professor Leaper highlighted that this 
choice is especially problematic in times 
of economic hardship when there are 
so many innovative and new products 
around, such as portable negative pressure, 
silver dressings, honey or matrices.
Professor Leaper added that large tranches 
of academia are dedicated to helping 
clinicians decide exactly what they should 
do when confronted with a wound and 
he examined some of the key points of 
evidence and research in the development 
of modern wound care, starting with 
George Winter’s theory of moist wound 
healing (Winter, 1962), which he 
highlighted has passed into wound care 
lore even though the original research 
featured pigs rather than humans!
Professor Leaper also highlighted 
Terry Turner’s work identifying the 
characteristics of the ideal surgical 
dressing, including (Leaper, 2006):
 Absorbent and removes excess 
exudate
 Provides moist environment 
(auto-debridement)
 Does not add any foreign body to 
the wound
 Avoids ‘strikethrough’ 
 Maintains skin temperature and 
gaseous exchange
 Permits pain free and atraumatic 
changes
 Cost effective
 Aids in control of bioburden 
(antiseptics).
Professor Leaper then discussed the 
work of David Sackett in evidence-
based medicine (Sackett, 1996), which 
highlighted:
 Conscientious, explicit, and judicious 
use of current best evidence in making 
decisions about care of individual 
patients
 Integrating individual clinical expertise 
with the best external evidence from 
systematic research.
Dr Sackett believed that choice in best 
practice relied on evidence, expertise, and 
listening to the patient. 
THE DEBATE
The debate sought to represent each 
method for choosing dressings with the 
panellists agreeing to support the 
following areas:
 Simon Barrett — symptom control 
(quality of life) 
 Karen Ousey — evidence-based care
 Carol Roberts — cost and using 
formularies   
 Julian Guest — health economics.
Delegates vote in the Wounds UK debate on dressing choice.
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hardship when 
there are so 
many innovative 
products around’ 
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Simon Barrett: symptom control
Simon Barrett spoke on the side of 
symptom control being the most efficient 
marker for wound dressing choice. 
He highlighted that the ideal dressing 
should:
 Maintain a moist wound 
environment, allowing excess fluid 
to be removed from the wound bed, 
without causing strikethrough to the 
outer dressing
 Act as a barrier to micro-organisms, 
managing bacterial burden where 
required and controlling odour
 Be non-adherent, easy to apply and 
remove without trauma
 Be non-toxic, non-allergenic and 
non-sensitising
 Be user-friendly to patient, clinician 
and the Trust in a cost – and quality 
– effective manner.
Barrett showed the audience a set of 
patient photos to demonstrate that you 
cannot always put a price on wound care 
treatment plans as they should remain 
individual to the patients specific needs 
(Figures 1–3).
For Barrett, the choice of dressing 
involves far more that simply the cost  
of the dressing — quality of life outcomes 
and service provision implications 
are also vital. At this early stage of 
the proceedings, Barrett’s theory that 
optimum dressing choice should be 
decided by the patient’s symptoms, 
received an enthusiastic response, with  
a large show of green cards.
Karen Ousey: evidence-based 
practice
Karen Ousey spoke next and although 
she agreed with Barrett that optimum 
dressing choice should be decided by 
the patient’s symptoms, she argued 
that without an understanding of the 
underpinning research and evidence 
to support dressing choices, there was 
potential for inappropriate choices  
to be made. 
She highlighted that although there 
were limited randomised controlled 
trials in the area of wound care there 
was an abundance of case studies and 
suggested that these clearly exemplified 
the effectiveness of a range of dressings on 
a variety of wound types. She recognised 
that while case studies were not seen as 
being ‘gold standard’ in the hierarchy of 
research, they should not be dismissed, 
but rather seen as good forms of evidence. 
In fact, she referred to Sackett et al 
(1996) who identified that the practice 
of evidence-based medicine means 
integrating individual clinical expertise 
with the best available external clinical 
evidence from systematic research. 
Ousey proceeded to discuss and explore 
the importance of effective assessment, 
planning, implementation and evaluation 
of dressing procedures and asked the 
audience who generally undertakes this 
important role:
 Registered or non registered 
practitioners?
 Nurses or medical staff?
 Generalist or specialist nurses?
 Carers?
 Patients?
She argued that it was vitally important 
that whoever assessed the wound and 
subsequently decided on the dressing 
and further evaluation must have an in-
depth knowledge of the wound healing 
process and mode of action of chosen 
dressings. Without this knowledge, 
she argued, progression of the wound 
could not be effectively assessed and 
any deterioration in the wound healing 
process might be missed and not acted 
upon early enough. 
Ousey proceeded to debate whether 
tissue viability required a specialist nurse 
or if indeed the generalist nurse should 
be equipped with skills that would 
allow them to become autonomous in 
managing skin integrity. The audience 
‘While case 
studies may not 
be considered 
Gold Standard, 
they should not be 
dismissed, but rather 
seen as good forms of 
evidence’
Figure 1: A mixed aetiology ulcer. 
Managing the symptom will im-
prove the patient’s level of concor-
dance, thereby improving his or her 
quality of life.
Figure 2: An abdominal surgical 
wound with vast levels of exudate. 
This required multiple dressing 
changes each day until further  
surgical intervention was performed. 
Figure 3: An patient at end of life 
with pressure damage to the sa-
crum. The aim here was to provide 
comfort and conformability.
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identified that they believed a specialist 
nurse was needed and Ousey agreed, 
stating that tissue viability nurse 
specialists had the opportunity to 
make a difference to the care of 
patients requiring all aspects of skin 
management and that their role should 
encompass that of educator, strategic 
planner, manager and advisor. 
She concluded that, although choice 
of wound dressing is individual and 
based on patient’s symptoms, an 
informed effective choice cannot be 
made if practitioners do not understand 
research and the evidence supporting 
the use of the dressings. 
Carol Roberts: cost and using the 
formulary
Next up was Carol Roberts, who 
mounted a spirited defence of using the 
formulary as tool for making wound 
dressing decisions.
Return on investment of the dressing 
versus unit price 
Roberts highlighted that when deciding 
on a dressing, there was always more to 
consider than simply the unit price as 
a number of other variables come into 
play, including:
 Total cost of treatment will include 
number of GP consultations, district 
nurse time, length of time treated, 
hospital admissions, the cost of any 
co-treatments e.g. pain medication
 Reduce overall cost – patient care 
pathway
 Effective measurement of outcomes.
A trained prescriber using a formulary 
is more likely to take these other factors 
into account when choosing a dressing.
Appropriate use
It is also important to make sure a 
dressing is appropriate for use with 
a patient (the right patient, right 
dressing, right time). Dressings that 
are not appropriate to the wound can 
potentially:
 Increase heal time
 Lead to further/prolonged infection
 Reduce patient confidence in
 treatment
 Threaten compliance.
It is vital to consider the patient’s 
perspective and wound management 
should always be a partnership between 
clinician and patient.
Frequency of use/dressing changes
Roberts argued that the formulary 
can be used to plan the potential 
expenditure on a dressing regimen as 
less frequent changes usually means 
less overall cost as well as fewer district 
nurse visits, for example.
Similarly, the frequency of dressing 
change needs to be tailored to the 
particular wound as factors such 
as increased exudate, for example, 
will increase the number of changes 
required.
Avoidance of secondary care admission/
referrals
A dressing that is chosen appropriately 
from a formulary can also reduce  
the amount of admissions needed  
from secondary care, as well as follow-
up in the form of clinic visits and 
district nursing time, etc. Patients 
who have had their dressings chosen 
inappropriately may need admissions 
due to:
 Non-healing – dressing failure
 Non-compliance
 More serious infection – systemic
 The increased knowledge of 
prescribers who have been trained 
to choose from a formulary 
increases the likelihood of referring 
only when necessary.
Avoidance of waste
Prescribing appropriately from a 
formulary also helps to avoid waste 
in the form of fewer dressings being 
discarded by patients through non-
concordance, or dressings being 
discarded by clinicians for not 
performing the correct task, i.e. 
reducing infection. Prescribing from a 
formulary mitigates against:
 Inappropriate type of dressings 
being prescribed
 Overprescribing
 Non-compliance
 Basic dressing packs for each patient 
can contain equipment that is  
not needed
 Hoarding by patients or care homes.
The X Factor: holistic approach best
Roberts wound up her section of the 
debate by emphasising that obviously, a 
‘Prescribing from 
a formulary helps 
to avoid waste 
in the form of 
fewer dressings 
discarded’
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holistic approach to dressing choice is 
best, including:
 Overall cost should encompasses all 
factors discussed above
 Informed and educated prescribing
 Involvement of multidisciplinary 
team when developing formulary – 
ownership improves adherence
 Ideally include a range of dressings 
in formulary to contend with needs 
of patients and prescriber
 Choice but limited with regular 
review points.
Julian Guest: health economics
The final presentation was from Julian 
Guest, who felt strongly that dressing 
choice should be predicated on 
health economics. He started with an 
explanation of health economics and 
was at pains to point out that despite 
its reputation as a rather dry, analytical 
area, health economics does in fact have 
a practical, clinical application when 
it comes to decision-making, such as 
choosing a therapy.
What is health economics?
Health economics is the study of 
allocating limited health care resources 
among unlimited demands to achieve 
the maximum health benefit for society.
What is economic evaluation?
Economic evaluation (e.g. cost-
effectiveness analysis) provides a 
framework to systematically compare 
two or more alternatives in terms of 
their costs and likely health outcomes, 
such as probability of wound healing or 
changes in health-related quality of life. 
What are the benefits of using cost-
effectiveness data to inform patients’ 
management decisions?
If your practice increasingly manages 
patients in a cost-effective manner, it 
should be possible to manage more patients 
within a fixed budget and time frame. 
What is included in a cost-effectiveness 
analysis?
A cost-effectiveness analysis of comparative 
treatments, in this case dressings, would be 
informed by the available evidence (from 
published literature, clinical trials, etc) and 
would consider:
 Probability of events occurring 
(e.g. probability of developing 
symptoms, adverse events, etc)
 Healthcare resource use and 
corresponding costs 
 Health effects/clinical outcomes 
 Subjective impact of treatment on 
patients, i.e. health-related quality  
of life.
Benefit of economic evaluation
Economic evaluations facilitate the best 
possible use of available resources, such 
as nurse time or dressings, in a rational 
decision-making context in order to 
accrue maximum healthcare benefits 
from limited resources.
RESULT
While all of the speakers received their 
fair share of green cards throughout the 
debate, by the end the clear favourite 
with delegates was the case put forward 
by Julian Guest. 
This was mainly because the audience 
were able to see that while symptoms, 
evidence and using the formulary, were 
all valid options for choosing dressings, 
the health economic concept of using 
all of these variables to arrive at what 
is best for the patients was the most 
effective.
CONCLUSION
Apart from anything, this debate 
demonstrated how difficult it can  
be for modern wound care clinicians  
to choose the correct treatment for  
each patient.
It also highlighted that the best way 
forward when attempting to match 
a dressing to a wound is to take a 
holistic view, bearing in mind the 
patient’s symptoms, the evidence for 
individual treatments, the formulary 
recommendations as well as whether 
the chosen treatment is cost-effective 
and clinically beneficial over time.
In the end, the success of this debate 
lay not in identifying one definitive 
path of action that a clinician should 
follow when choosing a dressing, but 
rather that the practitioner should take 
into account a plethora of interrelated 
factors before choosing any product.
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